Japanese pharmaceutical company with headquarters in Osaka, founded in 1878 as a medicine wholesaler and listed on the Tokyo market. Discovers and sells medicines for infectious disease, pain and central nervous system disorders, including the influenza treatment baloxavir and antibacterials such as cefiderocol, developed the HIV integrase inhibitor family behind ViiV Healthcare, and runs research centres and manufacturing plants in Japan with subsidiaries in Europe, the United States and Asia.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen